PMC:7067204 / 2914-4526
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"222","span":{"begin":1085,"end":1087},"obj":"Gene"},{"id":"223","span":{"begin":629,"end":631},"obj":"Gene"},{"id":"224","span":{"begin":1316,"end":1319},"obj":"Gene"},{"id":"225","span":{"begin":1255,"end":1258},"obj":"Gene"},{"id":"226","span":{"begin":868,"end":871},"obj":"Gene"},{"id":"227","span":{"begin":207,"end":210},"obj":"Gene"},{"id":"228","span":{"begin":1429,"end":1431},"obj":"Gene"},{"id":"229","span":{"begin":1140,"end":1142},"obj":"Gene"},{"id":"230","span":{"begin":1335,"end":1337},"obj":"Gene"},{"id":"231","span":{"begin":1273,"end":1275},"obj":"Gene"},{"id":"232","span":{"begin":1208,"end":1210},"obj":"Gene"},{"id":"233","span":{"begin":1088,"end":1090},"obj":"Gene"},{"id":"234","span":{"begin":939,"end":941},"obj":"Gene"},{"id":"235","span":{"begin":926,"end":928},"obj":"Gene"},{"id":"236","span":{"begin":917,"end":919},"obj":"Gene"},{"id":"237","span":{"begin":809,"end":811},"obj":"Gene"},{"id":"238","span":{"begin":26,"end":30},"obj":"Species"},{"id":"239","span":{"begin":52,"end":57},"obj":"Species"},{"id":"240","span":{"begin":77,"end":86},"obj":"Species"},{"id":"241","span":{"begin":107,"end":111},"obj":"Species"},{"id":"242","span":{"begin":113,"end":122},"obj":"Species"},{"id":"243","span":{"begin":136,"end":145},"obj":"Species"},{"id":"244","span":{"begin":159,"end":167},"obj":"Species"},{"id":"245","span":{"begin":184,"end":192},"obj":"Species"},{"id":"246","span":{"begin":211,"end":215},"obj":"Species"},{"id":"247","span":{"begin":226,"end":235},"obj":"Species"},{"id":"248","span":{"begin":240,"end":249},"obj":"Species"},{"id":"249","span":{"begin":441,"end":449},"obj":"Species"},{"id":"250","span":{"begin":461,"end":465},"obj":"Species"},{"id":"251","span":{"begin":471,"end":479},"obj":"Species"},{"id":"252","span":{"begin":491,"end":495},"obj":"Species"},{"id":"253","span":{"begin":1043,"end":1052},"obj":"Species"},{"id":"254","span":{"begin":1075,"end":1083},"obj":"Species"},{"id":"255","span":{"begin":1111,"end":1119},"obj":"Species"},{"id":"256","span":{"begin":1168,"end":1177},"obj":"Species"},{"id":"257","span":{"begin":1344,"end":1352},"obj":"Species"},{"id":"258","span":{"begin":1522,"end":1530},"obj":"Species"},{"id":"259","span":{"begin":278,"end":306},"obj":"Disease"},{"id":"260","span":{"begin":355,"end":383},"obj":"Disease"},{"id":"261","span":{"begin":520,"end":547},"obj":"Disease"},{"id":"262","span":{"begin":553,"end":588},"obj":"Disease"},{"id":"263","span":{"begin":632,"end":640},"obj":"Disease"},{"id":"264","span":{"begin":642,"end":653},"obj":"Disease"},{"id":"265","span":{"begin":700,"end":731},"obj":"Disease"},{"id":"266","span":{"begin":793,"end":802},"obj":"Disease"},{"id":"267","span":{"begin":929,"end":938},"obj":"Disease"},{"id":"268","span":{"begin":1148,"end":1157},"obj":"Disease"},{"id":"269","span":{"begin":1216,"end":1225},"obj":"Disease"},{"id":"270","span":{"begin":1362,"end":1367},"obj":"Disease"},{"id":"271","span":{"begin":1369,"end":1376},"obj":"Disease"},{"id":"272","span":{"begin":1378,"end":1387},"obj":"Disease"},{"id":"273","span":{"begin":1393,"end":1400},"obj":"Disease"},{"id":"274","span":{"begin":1509,"end":1513},"obj":"Disease"},{"id":"275","span":{"begin":1535,"end":1544},"obj":"Disease"}],"attributes":[{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"Gene:112935892"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"Gene:112935892"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Gene:25085"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"Gene:25085"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"Gene:25085"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Gene:25085"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"Gene:6999"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"Gene:6999"},{"id":"A230","pred":"tao:has_database_id","subj":"230","obj":"Gene:6688"},{"id":"A231","pred":"tao:has_database_id","subj":"231","obj":"Gene:6688"},{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"Gene:6688"},{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"Gene:6688"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"Gene:6688"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"Gene:6688"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"Gene:6688"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Gene:6688"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"Tax:11118"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"Tax:9606"},{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"Tax:11137"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"Tax:694002"},{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"Tax:31631"},{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:290028"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:694009"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:1335626"},{"id":"A246","pred":"tao:has_database_id","subj":"246","obj":"Tax:694002"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"Tax:31631"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"Tax:290028"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"Tax:694009"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"Tax:694002"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"Tax:1335626"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"Tax:694002"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"Tax:2697049"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"Tax:9606"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"Tax:9606"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"Tax:2697049"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"Tax:9606"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"Tax:9606"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:D012141"},{"id":"A260","pred":"tao:has_database_id","subj":"260","obj":"MESH:D012141"},{"id":"A261","pred":"tao:has_database_id","subj":"261","obj":"MESH:D012141"},{"id":"A262","pred":"tao:has_database_id","subj":"262","obj":"MESH:D012128"},{"id":"A263","pred":"tao:has_database_id","subj":"263","obj":"MESH:D003967"},{"id":"A264","pred":"tao:has_database_id","subj":"264","obj":"MESH:D008231"},{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"MESH:D009102"},{"id":"A266","pred":"tao:has_database_id","subj":"266","obj":"MESH:D003643"},{"id":"A267","pred":"tao:has_database_id","subj":"267","obj":"MESH:D011014"},{"id":"A268","pred":"tao:has_database_id","subj":"268","obj":"MESH:D007239"},{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"MESH:D011014"},{"id":"A270","pred":"tao:has_database_id","subj":"270","obj":"MESH:D005334"},{"id":"A271","pred":"tao:has_database_id","subj":"271","obj":"MESH:D005221"},{"id":"A272","pred":"tao:has_database_id","subj":"272","obj":"MESH:D003371"},{"id":"A273","pred":"tao:has_database_id","subj":"273","obj":"MESH:D004417"},{"id":"A274","pred":"tao:has_database_id","subj":"274","obj":"MESH:D003643"},{"id":"A275","pred":"tao:has_database_id","subj":"275","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":349,"end":372},"obj":"Body_part"},{"id":"T14","span":{"begin":514,"end":537},"obj":"Body_part"},{"id":"T15","span":{"begin":664,"end":669},"obj":"Body_part"},{"id":"T16","span":{"begin":1571,"end":1576},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma45662"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma45662"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":349,"end":372},"obj":"Body_part"},{"id":"T4","span":{"begin":355,"end":372},"obj":"Body_part"},{"id":"T5","span":{"begin":514,"end":537},"obj":"Body_part"},{"id":"T6","span":{"begin":520,"end":537},"obj":"Body_part"},{"id":"T7","span":{"begin":664,"end":669},"obj":"Body_part"},{"id":"T8","span":{"begin":1571,"end":1576},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":284,"end":306},"obj":"Phenotype"},{"id":"T4","span":{"begin":349,"end":383},"obj":"Phenotype"},{"id":"T5","span":{"begin":514,"end":547},"obj":"Phenotype"},{"id":"T6","span":{"begin":559,"end":579},"obj":"Phenotype"},{"id":"T7","span":{"begin":632,"end":640},"obj":"Phenotype"},{"id":"T8","span":{"begin":642,"end":653},"obj":"Phenotype"},{"id":"T9","span":{"begin":929,"end":938},"obj":"Phenotype"},{"id":"T10","span":{"begin":1216,"end":1225},"obj":"Phenotype"},{"id":"T11","span":{"begin":1362,"end":1367},"obj":"Phenotype"},{"id":"T12","span":{"begin":1369,"end":1376},"obj":"Phenotype"},{"id":"T13","span":{"begin":1378,"end":1387},"obj":"Phenotype"},{"id":"T14","span":{"begin":1393,"end":1400},"obj":"Phenotype"},{"id":"T15","span":{"begin":1535,"end":1544},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0011947"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002783"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0002783"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0031246"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":159,"end":167},"obj":"Disease"},{"id":"T17","span":{"begin":278,"end":306},"obj":"Disease"},{"id":"T18","span":{"begin":355,"end":386},"obj":"Disease"},{"id":"T19","span":{"begin":441,"end":449},"obj":"Disease"},{"id":"T20","span":{"begin":520,"end":547},"obj":"Disease"},{"id":"T21","span":{"begin":538,"end":547},"obj":"Disease"},{"id":"T22","span":{"begin":553,"end":588},"obj":"Disease"},{"id":"T23","span":{"begin":559,"end":588},"obj":"Disease"},{"id":"T24","span":{"begin":632,"end":640},"obj":"Disease"},{"id":"T25","span":{"begin":642,"end":653},"obj":"Disease"},{"id":"T26","span":{"begin":929,"end":938},"obj":"Disease"},{"id":"T27","span":{"begin":1148,"end":1157},"obj":"Disease"},{"id":"T28","span":{"begin":1216,"end":1225},"obj":"Disease"},{"id":"T29","span":{"begin":1535,"end":1544},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T37","span":{"begin":52,"end":57},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T38","span":{"begin":132,"end":133},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":155,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T40","span":{"begin":177,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T41","span":{"begin":224,"end":225},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T42","span":{"begin":349,"end":372},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"T43","span":{"begin":459,"end":460},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T44","span":{"begin":514,"end":537},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"T45","span":{"begin":664,"end":669},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T46","span":{"begin":664,"end":669},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T47","span":{"begin":689,"end":694},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T48","span":{"begin":822,"end":824},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T49","span":{"begin":885,"end":897},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"},{"id":"T50","span":{"begin":1021,"end":1028},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T51","span":{"begin":1041,"end":1042},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T52","span":{"begin":1408,"end":1410},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T53","span":{"begin":1432,"end":1433},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T54","span":{"begin":1519,"end":1521},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T55","span":{"begin":1571,"end":1576},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T26","span":{"begin":207,"end":427},"obj":"Sentence"},{"id":"T27","span":{"begin":428,"end":846},"obj":"Sentence"},{"id":"T28","span":{"begin":847,"end":997},"obj":"Sentence"},{"id":"T29","span":{"begin":998,"end":1084},"obj":"Sentence"},{"id":"T30","span":{"begin":1085,"end":1254},"obj":"Sentence"},{"id":"T31","span":{"begin":1255,"end":1315},"obj":"Sentence"},{"id":"T32","span":{"begin":1316,"end":1401},"obj":"Sentence"},{"id":"T33","span":{"begin":1402,"end":1514},"obj":"Sentence"},{"id":"T34","span":{"begin":1515,"end":1612},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
2_test
{"project":"2_test","denotations":[{"id":"31987001-15613317-27754478","span":{"begin":424,"end":425},"obj":"15613317"},{"id":"31987001-12711465-27754479","span":{"begin":841,"end":842},"obj":"12711465"},{"id":"31987001-27572168-27754480","span":{"begin":843,"end":844},"obj":"27572168"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}
MyTest
{"project":"MyTest","denotations":[{"id":"31987001-15613317-27754478","span":{"begin":424,"end":425},"obj":"15613317"},{"id":"31987001-12711465-27754479","span":{"begin":841,"end":842},"obj":"12711465"},{"id":"31987001-27572168-27754480","span":{"begin":843,"end":844},"obj":"27572168"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Prior to December 2019, 6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [lineage A], HCoV-HKU1 [lineage A], SARS-CoV [lineage B] and MERS-CoV [lineage C]). The βCoV lineage A HCoV-OC43 and HCoV-HKU1 usually cause self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly [4]. In contrast, SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively [5,6]. On 31 December 2019, the World Health Organization (WHO) was informed of cases of pneumonia of unknown cause in Wuhan City, Hubei Province, China [7]. Subsequent virological testing showed that a novel CoV was detected in these patients. As of 16 January 2020, 43 patients have been diagnosed to have infection with this novel CoV, including two exported cases of mild pneumonia in Thailand and Japan [8,9]. The earliest date of symptom onset was 1 December 2019 [10]. The symptomatology of these patients included fever, malaise, dry cough, and dyspnea. Among 41 patients admitted to a designated hospital in Wuhan, 13 (32%) required intensive care and 6 (15%) died. All 41 patients had pneumonia with abnormal findings on chest computerized tomography scans [10]."}